NCT01498003View on ClinicalTrials.gov

Tirofiban in Stenting for Long Coronary Lesion

PHASE4CompletedINTERVENTIONAL
Enrollment

748

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Coronary Artery Disease
Interventions
DRUG

tirofiban

10μg/kg bolus followed by 0.15μg/kg/min maintenance infusion for 12h

DRUG

normal saline solution

same use as tirofiban

Trial Locations (1)

200025

Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01498003 - Tirofiban in Stenting for Long Coronary Lesion | Biotech Hunter | Biotech Hunter